Pfizer Inc (NYSE:PFE)
| 44.48 BATS BZX Real-Time Price As of 11:16am ET |  +0.32 / +0.72%Today’s Change | 40.94 Today|||52-Week Range 61.71 | -24.67% Year-to-Date |
Latest PFE News | Press Releases
| Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks 9:10am / Zacks.com - Paid Partner Content | 2 Earnings Winners to Scoop Up During the Bear Market Sep 29 / StockNews.com - Paid Partner Content |
| The 3 Best Stocks to Buy This Week 5:16am / StockNews.com - Paid Partner Content | Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock Sep 28 / Zacks.com - Paid Partner Content |
| 2 Dividend Stocks to Double up on This Week Sep 29 / StockNews.com - Paid Partner Content | Pfizer (PFE) Seeks FDA Approval for Omicron Booster in Kids Sep 27 / Zacks.com - Paid Partner Content |
| EMA Accepts Moderna's (MRNA) Filing for Omicron BA.4, BA.5 Booster Sep 29 / Zacks.com - Paid Partner Content | Pfizer (PFE) Stock Moves -0.57%: What You Should Know Sep 26 / Zacks.com - Paid Partner Content |
| Pfizer (PFE), BNTX Seek EU Nod for Omicron Booster in Kids Sep 29 / Zacks.com - Paid Partner Content | Valneva (VALN) Stock Down 66% in the Past 6 Months: Here's Why Sep 26 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 44.16 |
| Today’s open | 44.29 |
| Day’s range | 44.06 - 44.58 |
| Volume | 5,444,766 |
| Average volume (3 months) | 19,342,685 |
| Market cap | $247.4B |
Data as of 11:16am ET, 09/30/2022
Growth & Valuation
| Earnings growth (last year) | +128.42% |
| Earnings growth (this year) | +47.13% |
| Earnings growth (next 5 years) | -10.50% |
| Revenue growth (last year) | +93.97% |
| P/E ratio | 8.6 |
| Price/Sales | 4.15 |
| Price/Book | 3.21 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ABBVAbbVie | -6.07 | -4.25% |
| MRKMerck | +0.45 | +0.52% |
| LLYEli Lilly and Co | -4.65 | -1.41% |
| NVONovo Nordisk | +0.09 | +0.09% |
Data as of 11:16am ET, 09/30/2022
Financials
| Next reporting date | November 1, 2022 |
| EPS forecast (this quarter) | $1.50 |
| Annual revenue (last year) | $81.3B |
| Annual profit (last year) | $22.1B |
| Net profit margin | 27.57% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
